The metabolism of glycosaminoglycans in the course of Graves' disease;Metabolizm glikozoaminoglikanów w przebiegu choroby Gravesa-Basedowa

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 60, Issue , 2006, Pages 184-191

  Winsz Szczotka, Katarzyna ^a   Komosińska Vassev, Katarzyna ^a   Olczyk, Krystyna ^a  

^a Diagnostyki Laboratoryjnej l skiej   (Poland)

Author keywords

Cytokines; Glycosaminoglycans; Graves' disease; Hyperthyroidism

Indexed keywords

GLYCOSAMINOGLYCAN;

AUTOIMMUNE DISEASE; CELL GRANULE; CELL MEMBRANE; EXTRACELLULAR MATRIX; GRAVES DISEASE; HUMAN; METABOLISM; REVIEW;

AUTOIMMUNE DISEASES; CELL MEMBRANE; CYTOPLASMIC GRANULES; ENGLISH ABSTRACT; EXTRACELLULAR MATRIX; GLYCOSAMINOGLYCANS; GRAVES DISEASE; HUMANS;

EID: 33846055577     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Akamizu T.: Antithyrotropin receptor antibody: an update. Thyroid, 2001; 11: 1123-1134
2. Allahabadia A., Daykin J., Holder R.L., Sheppard M.C., Gough S.C., Franklyn J.A.: Age and gender predict the outcome of treatment for Graves' hyperthyroidism. J. Clin. Endocrinol. Metab., 2000; 85: 1038-1042
3. Ando T., Davies T.F.: Monoclonal antibodies to the thyrotropin receptor. Clin. Dev. Immunol., 2005; 12: 137-143
4. Bahn R.S., Heufelder A.H.: Orbital connective tissue in endocrine ophthalmopathy. Dev. Ophthalmol., 1993; 25: 46-57
5. Bandtlow C.E., Zimmermann D.R.: Proteoglycans in the developing brain: new conceptual insights for old proteins. Physiol. Rev., 2000; 80: 1267-1290
6. Bjoro T., Holmen J., Kruger O., Midthjell K., Hunstad K., Schreiner T., Sandnes L., Brochmann H.: Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in large, unselected population. The Health Study of Nord-Trondelag (HUNT). Eur. J. Endocrinol., 2000; 143: 639-647
7. Borkakoti N.: Structural studies of matrix metalloproteinases. J. Mol. Med., 2000; 78: 261-268
8. Daumerie C., Ludgate M., Costagliola S., Many M.C.: Evidence for thyrotropin receptor immunoreactivity in pretibial connective tissue from patients with thyroid-associated dermopathy. Eur. J. Endocrinol., 2002; 146: 35-38
9. Day A.J., Sheehan J.K.: Hyaluronan: polysaccharide chaos to protein organisation. Curr. Opin. Struct. Biol., 2001; 11: 617-622
10. DeAngelis P.L.: Evolution of glycosaminoglycans and their glycosyltransferases: implications for the extracellular matrices of animals and the capsules of pathogenic bacteria. Anat. Rec., 2002; 268: 317-326
11. Fatourechi V.: Pretibial myxedema: pathophysiology and treatment options. Am. J. Clin. Dermatol., 2005; 6: 295-309
12. Filmus J.: Glypicans in growth control and cancer. Glycobiology, 2001; 11: 19R-23R
13. Funderburgh J.L.: Keratan sulfate: structure, biosynthesis, and function. Glycobiology, 2000; 10: 951-958
14. Głowacki A., Koźma E.M., Olczyk K., Kucharz E.J.: Glikozoaminoglikany-struktura i funkcja. Post. Biochem., 1995; 41: 139-148
15. Handel T.M., Johnson Z., Crown S.E., Lau E.K., Proudfoot A.E.: Regulation of protein function by glycosaminoglycans-as exemplified by chemokines. Annu. Rev. Biochem., 2005; 74: 385-410
16. Hansen C., Fraiture B., Rouhi R., Otto E., Förster G., Kahaly G.: HPLC glycosaminoglycan analysis in patients with Graves' disease. Clin. Sci., 1997; 92: 511-517
17. Hansen C., Rouhi R., Förster G., Kahaly G.J.: Increased sulfatation of glycosaminoglycans in Graves' ophthalmopathy. J. Clin. Endocrinol. Metab., 1999; 84: 1409-1413
18. Holm I.A., Manson J.E., Michels K.B., Alexander E.K., Willett W.C., Utiger R.D.: Smoking and other lifestyle factors and the risk of Graves' hyperthyroidism. Arch. Intern. Med., 2005;165: 1606-1611
19. Imai Y., Odajima R., Inoue Y., Shishiba Y.: Effect of growth factors on hyaluronan and proteoglycan synthesis by retroocular tissue fibroblasts of Graves' ophthalmopathy in culture. Acta Endocrinol., 1992; 126: 541-552
20. Kaback L.A., Smith T.J.: Expression of hyaluronan synthase messenger ribonucleic acid and their induction by interleukin-1b in human orbital fibroblasts: potential insight into the molecular pathogenesis of thyroid-associated ophthalmopathy. J. Clin. Endocrinol. Metab., 1999; 84: 4079-4084
21. Kahaly G., Förster G., Hansen C.: Glycosaminoglycans in thyroid eye disease. Thyroid, 1998; 8: 429-432
22. Kahaly G., Hansen C., Beyer J., Winand R.: Plasma glycosaminoglycans in endocrine ophthalmopathy. J. Endocrinol. Invest., 1994; 17: 45-50
23. Kahaly G., Schuler M., Sewell A.C., Bernard G., Beyer J., Krause U.: Urinary glycosaminoglycans in Graves' ophthalmopathy. Clin. Endocrinol., 1990; 33: 35-44
24. Kahaly G., Stover C., Beyer J., Otto E.: In vitro synthesis of glycosaminoglycans in endocrine ophthalmopathy. Acta Endocrinol., 1992; 127: 397-402
25. Kalmann R., Mourits M.P.: Diabetes mellitus: A risk in factor in patients with Graves' orbitopathy. Br. J. Ophthalmol., 1999; 83: 463-465
26. Komosińska-Vassev K., Olczyk K., Koźma E.M., Winsz-Szczotka K., Olczyk P., Wisowski G.: Graves' disease-associated changes in the serum lysosomal glycosidases activity and the glycosaminoglycan content. Clin. Chim. Acta, 2003; 331: 97-102
27. Komosińska-Vassev K., Olczyk K., Kucharz E.J., Marcisz C., Winsz-Szczotka K., Kotulska A.: Free radical activity and antioxidant defense mechanisms in patients with hyperthyroidism due to Graves' disease during therapy. Clin. Chim. Acta, 2000; 300: 107-117
28. Koźma E.M., Głowacki A., Olczyk K., Jaźwiec M.: Proteoglikany-struktura i funkcje. Postępy Biochem., 1997; 43: 158-172
29. Kresse H., Glössl J.: Glycosaminoglycan degradation. Adv. Enzymol. Relat. Areas Mol. Biol., 1987; 60: 217-311
30. Kresse H., Schönherr E.: Proteoglycans of extracellular matrix and growth control. J. Cell. Physiol., 2001; 189: 266-274
31. Kuroda K., Shinkai H.: Downregulation of decorin expression in dermal fibroblasts by interleukin-4. Arch. Dermatol. Res., 1997; 289: 476-480
32. Luegmayr E., Varga F., Frank T., Roschger P., Klaushofer K.: Effects of triiodothyronine on morphology, growth behavior, and the actin cytoskeleton in mouse osteoblastic cells (MC3T3-E1). Bone, 1996; 18: 591-599
33. Makihira S., Yan W., Murakami H., Furukawa M., Kawai T., Nikawa H., Yoshida E., Hamada T., Okada Y., Kato Y.: Thyroid hormone enhances aggrecanase-2/ADAM-TS5 expression and proteoglycan degradation in growth plate cartilage. Endocrinology 2003; 144: 2480-2488
34. Martins J.R., Furlanetto R.P., Oliveira L.M., Mendes A., Passerotti C.C., Chiamolera M.I., Rocha A.J., Manso P.G., Nader H.B., Dietrich C.P., Maciel R.M.: Comparison of practical methods for urinary glycosaminoglycans and serum hyaluronan with clinical activity scores in patients with Graves' ophthalmopathy. Clin. Endocrinol. (Oxf.), 2004; 60: 726-733
35. Metcalfe R.A., Davies R., Weetman A.P.: Analysis of fibroblast-stimulating activity in IgG from patients with Graves dermopathy. Thyroid, 1993; 3: 207-212
36. Moseley R., Waddington R.J., Embery G.: Degradation of glycosaminoglycans by reactive oxygen species derived from stimulated polymorphonuclear leukocytes. Biochim. Biophys. Acta, 1997; 1362: 221-231
37. Moseley R., Waddington R.J., Embery G.: Hyaluronan and its potential role in periodontal healing. Dent. Update, 2002; 29: 144-148
38. Moseley R., Waddington R., Evans P., Halliwell B., Embery G.: The chemical modification of glycosaminoglycan structure by oxygen-derived species in vitro. Biochim. Biophys. Acta, 1995; 1244: 245-252
39. Nagayama Y.: Animal models of Graves' hyperthyroidism. Endocr. J., 2005; 52: 385-394
40. Natt N., Bahn R.S.: Cytokines in the evolution of Graves' ophthalmopathy. Autoimmunity, 1997; 26: 129-136
41. Nauman J., Nauman A.: Choroba Gravesa-Basedowa; etiopatogeneza, klinika, leczenie. Endokrynol. Pol., 1995; 46: 3-8
42. Ohtsuka Y., Yamamoto K., Goto Y., Mizuta T., Ozaki I., Setoguchi Y., Kohda H., Saki T.: Localized myxedema, associated with increased serum hyaluronic acid, and response steroid pulse therapy. Intern. Med., 1995; 34: 424-429
43. Pappa A., Jackson P., Stone J., Munro P., Fells P., Pennock C., Lightman S.: An ultrastructural and systemic analysis of glycosaminoglycans in thyroid-associated ophthalmopathy. Eye, 1998; 12: 237-244
44. Pereira R C, Jorgetti V, Canalis E.: Triiodothyronine induces collagenase-3 and gelatinase B expression in murine osteoblasts. Am. J. Physiol., 1999; 277: E496-E504
45. Pilarska K., Kulig K., Krzystolik Z.: Ocena wydalania z moczem glikozoaminoglikanów (GAG) w trakcie leczenia postępującej oftalmopatii obrzękowo-naciekowej w przebiegu choroby Gravesa-Basedowa. Pol. Arch. Med. Wewn., 2001; 105: 139-144
46. Prabhakar B.S., Bahn R.S., Smith T.J.: Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr. Rev., 2003; 24: 802-835
47. Priestley G.C., Aldridge R.D., Hurel S.: Urinary glycosaminoglycans excretion in Graves' disease. Acta Derm. Venereol., 1996; 76: 368-370
48. Pritchard J., Horst N., Cruikshank W., Smith T.J.: Igs from patients with Graves' disease induce the expression of T cell chemoattractants in their fibroblasts. J. Immunol., 2002; 168: 942-950
49. Prydz K., Dalen K.T.: Synthesis and sorting of proteoglycans. J. Cell Sci., 2000; 113: 193-205
50. Raman R., Sasisekharan V., Sasisekharan R.: Structural insights into biological roles of protein-glycosaminoglycan interactions. Chem. Biol., 2005; 12: 267-277
51. Reid J.R., Wheeler S.F.: Hyperthyroidism: diagnosis and treatment. Am. Fam. Physician., 2005; 72: 623-630
52. Salvi M., Pedrazzoni M., Girasole N., Giuliani N., Minelli R., Wall J.R., Roti E.: Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking. Eur. J. Endocrinol., 2000; 143: 197-202
53. Shinohara M., Hamasaki Y., Katayama I.: Refractory pretibial myxoedema with response to intralesional insulin-like growth factor-1 antagonist (octreotide): downregulation of hyaluronic acid production by the lesional fibroblasts. Brit. J. Dermatol., 2000; 143: 1083-1086
54. Shishiba Y., Takeuchi Y., Yokoi N., Ozawa Y., Shimizu T.: Thyroid hormone excess stimulates the synthesis of proteoglycan in human skin fibroblasts in culture. Acta Endocrinol. (Copenh.), 1990; 123: 541-549
55. Smith B.R.: Thyroid autoantibodies. Scand. J. Clin. Lab. Invest. Suppl., 2001; 235: 45-52
56. Smith T.J., Bahn R.S., Gorman C.A., Cheavens M.: Stimulation of glycosaminoglycan accumulation by interferon gamma in cultured human retroocular fibroblasts. J. Clin. Endocrinol. Metab., 1991; 72: 1169-1171
57. Smith T.J.: Insights into the role of fibroblasts in human autoimmune diseases. Clin. Exp. Immunol., 2005;141: 388-397
58. Smith T.J.: Orbital fibroblasts exhibit a novel pattern of responses to proinflammatory cytokines: potential basis for the pathogenesis of thyroid-associated ophthalmopathy. Thyroid, 2002; 12: 197-203
59. Smith T.J.: Fibroblast biology in thyroid diseases. Curr. Opin. Endocrinol. Diabetes, 2002; 9: 393-400
60. Sugahara K., Kitagawa H.: Recent advances in the study of the biosynthesis and functions of sulfated glycosaminoglycans. Curr. Opin. Struct. Biol., 2000; 10: 518-527
61. Tan G.H., Dutton C.M., Bahn R.S.: Interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptor inhibit IL-1-induced glycosaminoglycan production in cultured human orbital fibroblasts from patients with Graves' ophthalmopathy. J. Clin. Endocrinol. Metab., 1996; 81: 449-452
62. Tao T.W., Leu S.L., Kriss J.P.: Biological activity of autoantibodies associated with Graves' dermopathy. J. Clin. Endocrinol. Metab., 1989; 69: 90-99
63. Tiedemann K., Malmström A., Westergren-Thorsson G.: Cytokine regulation of proteoglycan production in fibroblasts: separate and synergistic effects. Matrix Biol., 1997; 15: 469-478
64. Turnbull J., Powell A., Guimond S.: Heparan sulfate: decoding a dynamic multifunctional cell regulator. Trends Cell Biol., 2001; 11: 75-82
65. Volpé R.: Autoimmune endocrinopathies: aspects of pathogenesis and the role of immune assays in investigation and management. Clin. Chem., 1994; 40: 2132-2145
66. Vu T.H., Werb Z.: Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev., 2000; 14: 2123-2133
67. Wang L., Teng W., Shan Z.: Effect of INF-gamma, IL-4 on proliferation and synthesis of hyaluronic acid and collagen in cultured human retroorbital fibroblasts in vitro. Chin. Med. J. (Engl.), 2000; 113: 907-910
68. Winsz-Szczotka K., Olczyk K., Koźma E., Komosińska-Vassev K., Wisowski G., Marcisz C.: Glikozoaminoglikany surowicy krwi osób z chorobą Gravesa-Basedowa. Praca przyjęta do druku. Wiad. Lek. 2006; 1-2
69. Wong Y.K., Tang K.T., Wu J.C., Hwang J.J., Wang H.S.: Stimulation of hyaluronan synthesis by interleukin-1b involves activation of protein kinase C bII in fibroblasts from patients with Graves' ophthalmopathy. J. Cell. Biochem., 2001; 82: 58-67